Chemical Compound
Telmisartan; 4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic acid; 4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[[4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid; BIBR 277; BIBR 277SE; Kinzalmono; Micardis; Pritor; Telday; Telsar; Telsite
CAS Registry Number
144701-48-4
Primary record
Telmisartan; 4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic acid; 4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[[4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid; BIBR 277; BIBR 277SE; Kinzalmono; Micardis; Pritor; Telday; Telsar; Telsite
- 库存
- 3,299 克
- 纯度
- 98.5 %
- CAS
- 144701-48-4
化合物标识与属性
- CAS
- 144701-48-4
- PubChem CID
- 65999
- SMILES
- CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
- Canonical SMILES
- CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1
名称与同义词
- Telmisartan
- Micardis
- Pritor
- Kinzalmono
- 144701-48-4
- Semintra
- tolura
- Telmisattan
- Telmisartan Teva
- Targit
- Telmisartan-d3
- Kinzal
- Tazlok
- Telmisartan Actavis
- BIBR 277
- Kinzal/Pritor
- Telmisartan [INN]
- telmisartanum
- Telmisartana
- Telmisartar
- Telmisatran
- Telsite
- Micardis HCT
- Telday
- BIBR-277
- Temax
- Telmisartan CRS
- Micardis (TN)
- Kinzal;
- Pritor;
- Telma;
- BIBR 277SE
- Teleact D;
- Telmisartan Impurity
- BIBR-277-SE
- Telmisartan-13CD3
- Telmisartan [USAN:INN]
- BIBR-277SE
- BIBR 277 SE
- RefChem:6287
- Telmisartan (Micardis)
- Telmisartan (Standard)
- U5SYW473RQ
- UNII-U5SYW473RQ
- BIBR-277 SE
- C33H30N4O2
- TELMISARTAN [MI]
- Spectrum2_001976
- Spectrum3_001089
- Spectrum4_001261
- Spectrum5_001053
- CHEMBL1017
- TELMISARTAN [JAN]
- BIBR277
- DTXSID8023636
- MFCD00918125
- TELMISARTAN [HSDB]
- TELMISARTAN [USAN]
- D0N6RF
- Abbott brand of telmisartan
- TELMISARTAN [VANDF]
- TELMISARTAN TEVA PHARMA
- AC1L24EB
- AC1Q5U7O
- C09CA07
- SCHEMBL4464
- 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid
- CHEBI:9434
- DTXCID803636
- TELMISARTAN [MART.]
- Bay 68-9291
- BSPBio_002738
- GTPL592
- KBioGR_001842
- TELMISARTAN [USP-RS]
- TELMISARTAN [WHO-DD]
- HSDB 7590
- MLS000759432
- MLS001076687
- MLS001424174
- MLS006011851
- Widaplik component Telmisartan
- BIDD:GT0365
- SPECTRUM1505261
- SPBio_002131
- Telmisartan (JAN/USAN/INN)
- TELMISARTAN [EMA EPAR]
- orb1308143
- Telmisartan (JP17/USP/INN)
- ONDUARP COMPONENT TELMISARTAN
- SCHEMBL29356790
- SCHEMBL29414101
- SCHEMBL29691699
- Targit;Temax;BIBR277;Micardis
- Telmisartan - Bio-X trade mark
- TELMISARTAN [GREEN BOOK]
- Telmisartan [USAN:USP:INN:BAN]
- ERK5-3D20
- KBio3_001958
- TELMISARTAN [EP IMPURITY]
- TELMISARTAN [ORANGE BOOK]
- RMMXLENWKUUMAY-UHFFFAOYSA-N
- Telmisartan for system suitability
- YM-086
- GLXC-02564
- HMS1922P07
- HMS2051P16
- HMS2090P17
- HMS2093M22
- HMS2231P07
- HMS3393P16
- HMS3655C08
- HMS3715L17
- HMS3750E19
- HMS5079L20
- Pharmakon1600-01505261
- TELMISARTAN [EP MONOGRAPH]
- Telmisartan for peak identification
- TOLUCOMBI COMPONENT TELMISARTAN
- BAY68-9291
- Glaxo Wellcome brand of telmisartan
- KINZALKOMB COMPONENT TELMISARTAN
- PRITORPLUS COMPONENT TELMISARTAN
- TELMISARTAN [USP MONOGRAPH]
- ALBB-028954
- BCP04513
- CID65999
- GlaxoSmithKline brand of telmisartan
- KS-00000D1K
- MSK10070
- TWYNSTA COMPONENT TELMISARTAN
- ZINC1530886
- Tox21_111452
- BBL029085
- BDBM50043280
- CCG-39514
- CID:65999
- DL-511
- EBC-02079
- HB2558
- HY-13955R
- MICARDISPLUS COMPONENT TELMISARTAN
- NCGC00095150-01
- NP3429
- NSC759811
- s1738
- STK624049
- TU-199
- CPD000466326
- AKOS005557501
- C33-H30-N4-O2
- Telmisartan for system suitability CRS
- Telmisartan, >=98% (HPLC), solid
- Tox21_111452_1
- AB07687
- AC-2013
- ACN-039971
- AM90292
- BLP-013904
- CS-1699
- CS-O-02439
- DB00966
- FT15497
- KS-1215
- NC00296
- NSC 759811
- NSC-759811
- Telmisartan for peak identification CRS
- BAY-68-9291
- Boehringer Ingelheim brand of telmisartan
- MICARDIS HCT COMPONENT TELMISARTAN
- NCGC00095150-02
- NCGC00095150-03
- NCGC00095150-04
- NCGC00095150-06
- NCGC00095150-07
- NCGC00095150-08
- TELMISARTAN [EMA EPAR VETERINARY]
- [1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-
- 4CA-1224
- AJ-26708
- AK-72892
- AN-14373
- BR-72892
- BT164444
- HY-13955
- LS-44263
- SAM001246602
- SC-12741
- SMR000466326
- SY052776
- 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
- BCP0726000055
- SBI-0206733.P001
- SID:376229612
- AB0012010
- AB2000262
- J556.167A
- ST2410854
- TL8000991
- A8531
- CAS-144701-48-4
- FT-0631170
- FT-0674836
- NS00000398
- SW197676-3
- T-170
- T2861
- A10905
- C07710
- D00627
- EN300-123532
- J10282
- S-2837
- Telmisartan-[d4] (benzyl-[2,3,5,6-d4])
- 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
- 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
- 66930-EP2270011A1
- 66930-EP2272841A1
- 66930-EP2277866A1
- 66930-EP2277879A1
- 66930-EP2295406A1
- 66930-EP2295422A2
- 66930-EP2298772A1
- 66930-EP2298779A1
- 66930-EP2301923A1
- 66930-EP2301931A1
- 66930-EP2301936A1
- 66930-EP2305219A1
- 66930-EP2305650A1
- 66930-EP2308839A1
- AB00639941-06
- AB00639941-07
- AB00639941_08
- AB00639941_09
- Micardis, Targit, Temax, BIBR277, Telmisartan
- 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
- 701T484
- A808270
- C084178
- L001035
- Q733186
- SR-01000759355
- I06-0281
- SR-01000759355-4
- SR-01000759355-5
- Telmisartan for system suitability CRS (Y0001003)
- BRD-K73999723-001-02-2
- BRD-K73999723-001-10-5
- BRD-K73999723-001-11-3
- (1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-
- D000077333
- Z1551967334
- Telmisartan, European Pharmacopoeia (EP) Reference Standard
- 1189889-44-8
- 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid
- 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
- 4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID
- Telmisartan, United States Pharmacopeia (USP) Reference Standard
- 1261396-33-1
- 2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid
- 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid
- 4'-(1,7'-DIMETHYL-2'-PROPYL-1H-[2,5']BIBENZOIMIDAZOLYL-3'-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID
- 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
- 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
- 4'-[[4-METHYL-6-(1-METHYL-2-BENZIMIDAZOLYL)-2-PROPYL-1-BENZIMIDAZOLYL]METHYL]-2-BIPHENYLCARBOXYLIC ACID
- 4'-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}-[1,1'-biphenyl]-2-carboxylic acid
- Telmisartan, Pharmaceutical Secondary Standard; Certified Reference Material
- 4-(1,4-Dimethyl-2-propyl-2,6-bi-1H-benzimidazol-1-yl)methyl-1,1-biphenyl-2-carboxylicacid
- Telmisartan for peak identification, European Pharmacopoeia (EP) Reference Standard
- Telmisartan for system suitability, European Pharmacopoeia (EP) Reference Standard
- [1,1'-Biphenyl]-2-carboxylic acid,4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-
- 2-(4-((4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl)methyl)phenyl)benzoic acid
- 2-(4-((4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl)methyl)phenyl)benzoic acid
- 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl] methyl}phenyl)benzoic acid
- 2-[4-[[4-Methyl-2-propyl-6-[1-(trideuterio(113C)methyl)benzimidazol-2-yl]benzimidazol-1-yl]methyl]phenyl]benzoic acid
- 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid.
- 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acidBIBR-277
- 4 -(1 ,4-Dimethyl-2-propyl-6,2 -bi[1H-benzoimidazole]-1-ylmethyl)biphenyl-2-carboxylic acid
- 4 -(2-Propyl-4-methyl-6-(1-methyl-1H-benzoimidazole-2-yl)-1H-benzoimidazole-1-yl)methyl-biphenyl-2-carboxylic acid
- 4 -[(1,4 -Dimethyl-2 -propyl[2,6 -bi-1H-benzimidazol]-1 -yl)methyl]biphenyl-2-carboxylic acid
- 4 -[[2-Propyl-4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-1H-benzimidazol-1-yl]methyl]-1,1 -biphenyl-2-carboxylic acid
- 4 -[[4-Methyl-6-(1-methyl-1H-benzimidazole-2-yl)-2-propyl-1H-benzimidazole-1-yl]methyl]biphenyl-2-carboxylic acid
- 4'-[[1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl]-methyl]-1,1'-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester
- 4''-((1,4''-dimethyl-2''-propyl(2,6''-bi-1H-benzimidazol)-1''-yl)methyl)-(1,1''-biphenyl)-2-carboxylic acid
- 4''-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
- 4''-[(1,4''-dimethyl-2''propyl[2,6''-bi-1H-benzimidazol]-1''-yl)methyl]-[1,1''-biphenyl]-2-carboxylic acid
- 4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl][1,1''-biphenyl]-2-carboxylic acid
- 4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl]biphenyl-2-carboxylic acid
- 4'-((1,4'-dimethyl-2'propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
- 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carbox
- 4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylicacid
- 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl)biphenyl-2-carboxylic acid
- 4'-((1,7'-DIMETHYL-2'-PROPYL-1H,3'H-2,5'-BIBENZO[D]IMIDAZOL-3'-YL)METHYL)BIPHENYL-2-CARBOXYLIC ACID
- 4'-((4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl)methyl)biphenyl-2-carboxylic acid
- 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
- 4'-[(1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bi-1,3-benzimidazol]-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
- 4'-[[2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-biphenyl-2-carboxylic acid
- 4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid
- 4'-[[4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]- 2-biphenylcarboxylic acid
- 4'-[2-n-propyl-4-methyl-6-(1-methyl benzimidazol-2-yl)benzimidazol-1-yl methyl]biphenyl-2-carboxylic acid
- 620-494-7
- Telmisartan; 4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic acid; 4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[[4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid; BIBR 277; BIBR 277SE; Kinzalmono; Micardis; Pritor; Telday; Telsar; Telsite
- TLS